Vast Therapeutics, Inc. — Form C-U (Regulation Crowdfunding)
Vast Therapeutics, Inc. of MORRISVILLE, NC filed a Form C-U (Regulation Crowdfunding) with the SEC on 2025-03-25. Target raise $21K, up to $1.2M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-03-25
- Form: C-U
- Accession: 0001665160-25-000479
- Target amount: $21K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 20,000
- Price: $1.0400
- Deadline: 2025-03-17
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0002041605
- Website: www.vasttherapeutics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2017-04-05
- Address: 615 DAVIS DR. SUITE 800, MORRISVILLE, NC, 27560
- Employees: 8
Financials (as filed)
- Total assets (most recent): $44.5M
- Cash (most recent): $98K
- Revenue (most recent): $737K
- Net income (most recent): $-7.5M
- Net income (prior): $-6.3M
- Short-term debt: $1.8M
- Long-term debt: $10.0M
People (8)
| Name | Role | Location |
|---|
| Chuck Swoboda | Executive Chairman | Boston, MA |
| Mark Schoenfisch | Director | Research Triangle Park, NC |
| Mark Schoenfisch | Director and Chief Scientific Officer | Research Triangle Park, NC |
| Mark Schoenfisch | Director & Chief Scientific Officer | Research Triangle Park, NC |
| Nathan Stasko | Chief Executive Officer | Durham, NC |
| Nate Stasko | Chief Executive Officer, Director | Morrisville, NC |
| Charles Swoboda | Executive Chairman | Morrisville, NC |
| John Oakley | Chief Financial Officer | Morrisville, NC |
Reg CF filing history (6)
More